{"protocolSection":{"identificationModule":{"nctId":"NCT04285918","orgStudyIdInfo":{"id":"2019-1112"},"organization":{"fullName":"Asan Medical Center","class":"OTHER"},"briefTitle":"Evaluation of Prevalence and Clinical Impact of Atrial Fibrillation in Elderly Patients With Cryptogenic Stroke and High-Risk Patent Foramen Ovale","officialTitle":"Evaluation of Prevalence and Clinical Impact of Atrial Fibrillation in Elderly Patients With Cryptogenic Stroke and High-Risk Patent Foramen Ovale","acronym":"DefenseElderly"},"statusModule":{"statusVerifiedDate":"2020-02","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2019-10-02","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2024-10-02","type":"ESTIMATED"},"completionDateStruct":{"date":"2024-10-02","type":"ESTIMATED"},"studyFirstSubmitDate":"2020-02-25","studyFirstSubmitQcDate":"2020-02-25","studyFirstPostDateStruct":{"date":"2020-02-26","type":"ACTUAL"},"lastUpdateSubmitDate":"2020-02-25","lastUpdatePostDateStruct":{"date":"2020-02-26","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Jae-Kwan Song","investigatorTitle":"Jae-Kwan Song","investigatorAffiliation":"Asan Medical Center"},"leadSponsor":{"name":"Asan Medical Center","class":"OTHER"},"collaborators":[{"name":"Medtronic","class":"INDUSTRY"}]},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The purpose of DEFENSE-ELDERLY is to identify the prevalence of AF and evaluate the clinical impact of AF in elderly ESUS patients and no other known sources of stroke besides a high-risk patent foramen ovale, and compare it with elderly ESUS patients without high-risk PFO (no PFO or non-high risk PFOs)","detailedDescription":"The purpose of DEFENSE-ELDERLY is to identify the prevalence of AF and evaluate the clinical impact of AF in elderly ESUS patients and no other known sources of stroke besides a high-risk patent foramen ovale, and compare it with elderly ESUS patients without high-risk PFO (no PFO or non-high risk PFOs)"},"conditionsModule":{"conditions":["Cryptogenic Stroke","High Risk Patent Foramen Ovale"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":300,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Cohort A","description":"Patients ≥60 y/o with ESUS and PFO that is likely to have causative role (high-risk anatomical feature)","interventionNames":["Procedure: Percutaneous device closure"]},{"label":"Cohort B","description":"Patients ≥60 y/o with ESUS without PFO, or with non-high risk PFO"}],"interventions":[{"type":"PROCEDURE","name":"Percutaneous device closure","description":"If there is no relevant AF detected for 6 months during intermittent follow-up or ICM, device closure of PFO is recommended for high-risk PFOs but is decided ultimately at the discretion of the attending physician. If there is any relevant AF identified from ICM or other modalities during follow-up, adequate secondary prevention with anticoagulants should be carried out. All this process and decision making should be a part of routine clinical practice.","armGroupLabels":["Cohort A"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Paroxysmal AF episodes > 30 seconds detected with intermittent recordings or ≥ 2 minutes during ICM within 6 months","description":"Paroxysmal AF episodes \\> 30 seconds detected with intermittent recordings or ≥ 2 minutes during ICM within 6 months","timeFrame":"Enrollment to 6 months"}],"secondaryOutcomes":[{"measure":"Paroxysmal AF episodes > 30 seconds detected with intermittent recordings or ≥ 2 minutes during ICM within 36 months","description":"Paroxysmal AF episodes \\> 30 seconds detected with intermittent recordings or ≥ 2 minutes during ICM within 36 months","timeFrame":"Enrollment to 36 months"},{"measure":"Paroxysmal AF episodes > 30 seconds detected with intermittent recordings or ≥ 6 minutes during ICM at 6 months and 36 months","description":"Paroxysmal AF episodes \\> 30 seconds detected with intermittent recordings or ≥ 6 minutes during ICM at 6 months and 36 months","timeFrame":"6 months to 36 months"},{"measure":"Rates of percutaneous device closure, prescription of anticoagulants (warfarin or direct oral anticoagulants)","description":"Rates of percutaneous device closure, prescription of anticoagulants (warfarin or direct oral anticoagulants)","timeFrame":"Enrollment to 36 months"},{"measure":"Recurrent stroke or TIA","description":"Recurrent stroke or TIA","timeFrame":"Enrollment to 36 months"},{"measure":"All-cause death, Vascular Death","description":"All-cause death, Vascular Death","timeFrame":"Enrollment to 36 months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients ≥60 y/o with ESUS and PFO that is likely to have causative role (high-risk anatomical feature) (cohort A)\n* Patients ≥60 y/o with ESUS without PFO, or with non-high risk PFO (cohort B)\n* The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the institutional review board\n* Patients who are scheduled to have implantable cardiac monitoring\n\nExclusion Criteria:\n\n* Transient ischemic attack\n* Lacunar infarction (infarction at subcortical area with a lesion diameter less than 2cm on MR)\n* Presence of complex aortic atheroma (≥4mm in plaque thickness or presence of mobile components)\n* Presence of ≥50% luminal stenosis (extra- or intracranial) in arteries supplying the ischemic area\n* Unwillingness or inability to comply with the procedures described in this protocol\n* Life expectancy \\< 1 years for any non-cardiac or cardiac causes","healthyVolunteers":false,"sex":"ALL","minimumAge":"60 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Patients ≥60 y/o with ESUS and PFO that is likely to have causative role (high-risk anatomical feature) (cohort A) and Patients ≥60 y/o with ESUS without PFO, or with non-high risk PFO (cohort B)","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"Jae-Kwan Song","role":"CONTACT","phone":"+82 2 3010 3155","email":"jksong@amc.seoul.kr"},{"name":"Jong S Kim","role":"CONTACT","phone":"+82 2 3010 3442","email":"jongskim@amc.seoul.kr"}],"locations":[{"facility":"Asan Medical Center","status":"RECRUITING","city":"Seoul","country":"Korea, Republic of","contacts":[{"name":"Jae-Kwan Song","role":"CONTACT","phone":"+82 3 3010 3155","email":"jksong@amc.seoul.kr"}],"geoPoint":{"lat":37.566,"lon":126.9784}}]},"ipdSharingStatementModule":{"ipdSharing":"UNDECIDED"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000001281","term":"Atrial Fibrillation"},{"id":"D000054092","term":"Foramen Ovale, Patent"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000001145","term":"Arrhythmias, Cardiac"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000006344","term":"Heart Septal Defects, Atrial"},{"id":"D000006343","term":"Heart Septal Defects"},{"id":"D000006330","term":"Heart Defects, Congenital"},{"id":"D000018376","term":"Cardiovascular Abnormalities"},{"id":"D000000013","term":"Congenital Abnormalities"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M4276","name":"Atrial Fibrillation","asFound":"Atrial Fibrillation","relevance":"HIGH"},{"id":"M27260","name":"Foramen Ovale, Patent","asFound":"Patent Foramen Ovale","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Cryptogenic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M4143","name":"Arrhythmias, Cardiac","relevance":"LOW"},{"id":"M9109","name":"Heart Diseases","relevance":"LOW"},{"id":"M9122","name":"Heart Septal Defects, Atrial","relevance":"LOW"},{"id":"M9121","name":"Heart Septal Defects","relevance":"LOW"},{"id":"M9108","name":"Heart Defects, Congenital","relevance":"LOW"},{"id":"M12","name":"Congenital Abnormalities","relevance":"LOW"},{"id":"M20193","name":"Cardiovascular Abnormalities","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BC16","name":"Diseases and Abnormalities at or Before Birth"}]},"interventionBrowseModule":{"browseLeaves":[{"id":"M3934","name":"Anticoagulants","relevance":"LOW"}],"browseBranches":[{"abbrev":"AnCoag","name":"Anticoagulants"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}